- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
Results
187
13 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
187 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ZVRA | US$8.97 | 3.6% | 102.0% | US$478.8m | US$20.14 | PS19.6x | E73.5% | n/a | ||
AXSM | US$94.60 | -3.3% | 57.4% | US$4.6b | US$129.41 | PS13.5x | E72.4% | n/a | ||
ALNY | US$248.79 | -6.0% | 52.7% | US$30.2b | US$301.21 | PS15.3x | E70.7% | n/a | ||
SRPT | US$110.86 | -1.4% | 32.3% | US$10.2b | US$189.86 | PE86.9x | E42.6% | n/a | ||
TVTX | US$17.86 | -3.8% | 212.2% | US$1.5b | US$26.94 | PS7.6x | E72.5% | n/a | ||
TGTX | US$31.15 | -10.7% | 145.9% | US$4.4b | US$37.22 | PS16.9x | E56.5% | n/a | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
ITCI | US$85.64 | -2.9% | 44.5% | US$8.8b | US$101.87 | PS14.8x | E68.5% | n/a | ||
CLNN New | US$4.09 | -15.1% | -56.9% | US$37.2m | US$46.17 | PS77.5x | E60.7% | n/a | ||
AVDL | US$10.75 | -10.6% | n/a | US$1.0b | US$23.60 | PS7.5x | E64.2% | n/a | ||
BPMC | US$94.81 | -2.1% | 41.5% | US$6.0b | US$125.58 | PS13.9x | E68.6% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
OPTN | US$0.37 | -27.6% | -70.0% | US$51.1m | US$3.00 | PS0.7x | E70.0% | n/a | ||
URGN | US$11.45 | -5.8% | -8.6% | US$470.9m | US$39.93 | PS5.4x | E67.1% | n/a | ||
EVOK | US$4.56 | 7.0% | -69.7% | US$7.5m | US$18.00 | PS0.8x | E124.7% | n/a | ||
RNXT | US$1.19 | 9.2% | 83.4% | US$26.6m | US$5.25 | PB4x | E70.9% | n/a | ||
SWTX | US$37.44 | 7.9% | 80.8% | US$2.8b | US$67.33 | PS20.5x | E70.0% | n/a | ||
ABEO New | US$5.75 | -5.7% | 38.6% | US$256.8m | US$16.75 | PB5.5x | E62.9% | n/a | ||
ALDX | US$4.76 | 7.9% | 88.1% | US$294.2m | US$10.00 | PB3.3x | E71.6% | n/a | ||
RCEL | US$13.05 | 1.4% | 24.3% | US$339.9m | US$16.92 | PS5.7x | E77.5% | n/a | ||
MGTX | US$5.82 | -17.3% | 7.6% | US$467.4m | US$23.25 | PS32.7x | E7.1% | n/a | ||
MDGL | US$317.09 | 0.6% | 66.5% | US$6.9b | US$372.20 | PS90x | E73.1% | n/a | ||
TNYA | US$2.22 | 6.2% | 25.4% | US$179.8m | US$18.75 | PB1.6x | E61.5% | n/a |